Top

Cancer Cell International

Published in:

01-12-2020 | Breast Cancer | Primary research

A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis

Authors: Qiang Zhang, Xiaoyan Jin, Wenbiao Shi, Xin Chen, Wenyang Pang, Xiaodong Yu, Linjun Yang

Published in: Cancer Cell International | Issue 1/2020

Abstract

Background

The purpose of this study was to explore the regulatory mechanism of the long non-coding RNA (lncRNA) LINC00461 underlying the breast cancer invasion and migration via the miR-144-3p/KPNA2 axis.

Methods

Bioinformatics methods were applied to screen differentially expressed mRNAs, miRNAs and lncRNAs for construction of a competing endogenous RNA (ceRNA) network. LINC00461, KPNA2 and miR-144-3p were identified, and KPNA2 was predicted to be a target of miR-144-3p and significantly correlated with breast cancer prognosis. To make the findings more convincible, we used qRT-PCR to detect the expression levels of LINC00461 and miR-144-3p in breast cancer cells, and conducted western blot to determine KPNA2 protein level. Then, RIP was performed to assess the combination between miR-144-3p and LINC00461 or KPNA2, and dual-luciferase reporter assay was used to validate the targeted relationship between miR-144-3p and KPNA2. Furthermore, Transwell was employed for the examination of cell invasion and migration in breast cancer.

Results

LINC00461 was predicted to regulate KPNA2 through sponging miR-144-3p as revealed by the ceRNA network. Besides, LINC00461 and KPNA2 were found to be remarkably highly-expressed in breast cancer cells, while miR-144-3p was poorly-expressed. Silencing LINC00461 could promote miR-144-3p expression, thus inhibiting cell invasion and migration. In addition, KPNA2 was confirmed to be a direct target of miR-144-3p. Silencing miR-144-3p or overexpressing KPNA2 could reverse the inhibitory effect of LINC00461 silencing on cell invasion and migration in breast cancer.

Conclusion

LINC00461 promoted the expression of KPNA2 by competitively binding to miR-144-3p, thereby promoting the invasion and migration of breast cancer cells.

Chen W, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32. https://doi.org/10.3322/caac.21338.CrossRefPubMed

Polyak K. Breast cancer: origins and evolution. J Clin Investig. 2007;117:3155–63. https://doi.org/10.1172/JCI33295.CrossRefPubMedPubMedCentral

Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med. 2018;24:257–77. https://doi.org/10.1016/j.molmed.2018.01.001.CrossRefPubMedPubMedCentral

Liu W. LncRNA LINC-PINT Inhibits cancer cell proliferation, invasion, and migration in osteosarcoma by downregulating miRNA-21. Cancer Biother Radiopharm. 2019;34:258–63. https://doi.org/10.1089/cbr.2018.2684.CrossRefPubMed

Li WX, et al. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival. Eur Rev Med Pharmacol Sci. 2017;21:3397–401.PubMed

Deng LL, et al. LINC00978 predicts poor prognosis in breast cancer patients. Sci Rep. 2016;6:37936. https://doi.org/10.1038/srep37936.CrossRefPubMedPubMedCentral

Li H, et al. Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer. Mol Carcinog. 2017;56:3–17. https://doi.org/10.1002/mc.22338.CrossRefPubMed

Chen DQ, et al. Long non-coding RNA LINC00628 suppresses the growth and metastasis and promotes cell apoptosis in breast cancer. Eur Rev Med Pharmacol Sci. 2017;21:275–83.PubMed

Yang Y, et al. LINC00461, a long non-coding RNA, is important for the proliferation and migration of glioma cells. Oncotarget. 2017;8:84123–39. https://doi.org/10.18632/oncotarget.20340.CrossRefPubMedPubMedCentral

10.

Ji D, Wang Y, Li H, Sun B, Luo X. Long non-coding RNA LINC00461/miR-149-5p/LRIG2 axis regulates hepatocellular carcinoma progression. Biochem Biophys Res Commun. 2019;512:176–81. https://doi.org/10.1016/j.bbrc.2019.03.049.CrossRefPubMed

11.

Dong L, Qian J, Chen F, Fan Y, Long J. LINC00461 promotes cell migration and invasion in breast cancer through miR-30a-5p/integrin beta3 axis. J Cell Biochem. 2019;120:4851–62. https://doi.org/10.1002/jcb.27435.CrossRefPubMed

12.

Chen X, et al. Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer. Clin Cancer Res. 2018;24:2002–14. https://doi.org/10.1158/1078-0432.CCR-17-2376.CrossRefPubMed

13.

Sui J, et al. Long non-coding RNA Linc-USP16 functions as a tumour suppressor in hepatocellular carcinoma by regulating PTEN expression. Cell Physiol Biochem. 2017;44:1188–98. https://doi.org/10.1159/000485449.CrossRefPubMed

14.

Lu W, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer. 2017;16:118. https://doi.org/10.1186/s12943-017-0685-9.CrossRefPubMedPubMedCentral

15.

Kong YG, et al. LncRNA-LINC00460 facilitates nasopharyngeal carcinoma tumorigenesis through sponging miR-149-5p to up-regulate IL6. Gene. 2018;639:77–84. https://doi.org/10.1016/j.gene.2017.10.006.CrossRefPubMed

16.

Xie M, et al. The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR. Cancer Lett. 2019;443:67–79. https://doi.org/10.1016/j.canlet.2018.11.032.CrossRefPubMed

17.

Ren M, Xu W, Xu T. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway. Artif Cells Nanomed Biotechnol. 2019;47:1014–21. https://doi.org/10.1080/21691401.2019.1584566.CrossRefPubMed

18.

Liu XH, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92. https://doi.org/10.1186/1476-4598-13-92.CrossRefPubMedPubMedCentral

19.

Chen L, et al. Erratum to: the expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer. J Transl Med. 2016;14:318. https://doi.org/10.1186/s12967-016-1069-4.CrossRefPubMedPubMedCentral

20.

Qian B, et al. Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer. Thorac Cancer. 2018;9:589–97. https://doi.org/10.1111/1759-7714.12623.CrossRefPubMedPubMedCentral

21.

Yang L, et al. High expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma. J Cancer. 2017;8:97–103. https://doi.org/10.7150/jca.16819.CrossRefPubMedPubMedCentral

22.

Xu B, et al. Expression of long noncoding RNA LINC01358 in prostate cancer and its effect on the proliferation and migration of prostate cancer cells. Zhonghua Nan Ke Xue. 2016;22:1083–7.PubMed

23.

Yan M, et al. Long noncoding RNA linc-ITGB1 promotes cell migration and invasion in human breast cancer. Biotechnol Appl Biochem. 2017;64:5–13. https://doi.org/10.1002/bab.1461.CrossRefPubMed

24.

Hu XL, Wang J, He W, Zhao P, Wu WQ. Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells. Eur Rev Med Pharmacol Sci. 2018;22:3074–84. https://doi.org/10.26355/eurrev_201805_15067.CrossRefPubMed

25.

Yin Y, Cai J, Meng F, Sui C, Jiang Y. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55. Cancer Biol Ther. 2018;19:306–15. https://doi.org/10.1080/15384047.2017.1416934.CrossRefPubMedPubMedCentral

26.

Pan Y, Zhang J, Fu H, Shen L. miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process. Onco Targets Ther. 2016;9:6247–55. https://doi.org/10.2147/OTT.S103650.CrossRefPubMedPubMedCentral

27.

van der Watt PJ, et al. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer. 2009;124:1829–40. https://doi.org/10.1002/ijc.24146.CrossRefPubMedPubMedCentral

28.

Sakai M, et al. Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma. Anticancer Res. 2010;30:851–6.PubMed

29.

Wang CI, et al. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer. 2011;128:2364–72. https://doi.org/10.1002/ijc.25568.CrossRefPubMed

30.

Yoshitake K, et al. Importin-alpha1 as a novel prognostic target for hepatocellular carcinoma. Ann Surg Oncol. 2011;18:2093–103. https://doi.org/10.1245/s10434-011-1569-7.CrossRefPubMed

31.

Huang L, et al. KPNA2 promotes migration and invasion in epithelial ovarian cancer cells by inducing epithelial–mesenchymal transition via Akt/GSK-3beta/Snail activation. J Cancer. 2018;9:157–65. https://doi.org/10.7150/jca.20879.CrossRefPubMedPubMedCentral

Title: A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis
Authors: Qiang Zhang
Xiaoyan Jin
Wenbiao Shi
Xin Chen
Wenyang Pang
Xiaodong Yu
Linjun Yang
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Breast Cancer
Breast Cancer
Published in: Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-020-01221-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Long noncoding RNA SNHG6 mainly functions as a competing endogenous RNA in human tumors

Overexpression of FES might inhibit cell proliferation, migration, and invasion of osteosarcoma cells

A novel risk score system of immune genes associated with prognosis in endometrial cancer

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma

Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis

The fiber metabolite butyrate reduces gp130 by targeting TRAF5 in colorectal cancer cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer